Nurix Therapeutics reported total assets of $535.54M and total liabilities of $132.91M for the quarter ended May 2026, down 9.5% year over year. This balance sheet covers 28 quarters of results from Aug 2019 through May 2026, standardized by Business Quant from the company’s SEC filings.
| Balance Sheet | Aug2019 | Nov2019 | Feb2020 | May2020 | Aug2020 | Nov2020 | Feb2021 | May2021 | Aug2021 | Nov2021 | Feb2022 | May2022 | Aug2022 | Nov2022 | Feb2023 | May2023 | Aug2023 | Nov2023 | Feb2024 | May2024 | Aug2024 | Nov2024 | Feb2025 | May2025 | Aug2025 | Nov2025 | Feb2026 | May2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||||||||||
| Current Assets | ||||||||||||||||||||||||||||
| Cash & EquivalentsCash & Equiv. | 147.44M | 80.51M | 78.78M | 41.53M | 47.56M | 64.47M | 33.57M | 58.96M | 42.30M | 54.63M | 49.81M | 116.79M | 99.04M | 110.00M | 75.92M | 84.26M | 78.44M | 246.96M | 71.19M | 67.69M | ||||||||
| Short-term InvestmentsInvestments (Current) | 196.46M | 215.21M | 183.20M | 255.75M | 296.92M | 244.67M | 243.57M | 222.22M | 216.55M | 233.28M | 194.18M | 326.35M | 349.01M | 499.59M | 473.76M | 401.52M | 350.39M | 345.98M | 469.54M | 375.84M | ||||||||
| Cash & Current Investments | 343.90M | 295.72M | 261.98M | 297.28M | 344.48M | 309.14M | 277.15M | 281.18M | 258.85M | 287.91M | 243.99M | 443.14M | 448.05M | 609.58M | 549.68M | 485.78M | 428.83M | 592.94M | 540.73M | 443.53M | ||||||||
| Receivables - NetNet Receivables | 5.00M | 6.00M | 6.00M | 1.50M | 2.50M | 5.00M | 2.00M | 4.00M | 2.00M | 5.00M | 7.00M | 19.00M | 5.00M | |||||||||||||||
| Receivables - OtherOther Receivables | 5.00M | 0.90M | 0.90M | 0.70M | 1.10M | 1.10M | 1.20M | 1.00M | 0.80M | 0.80M | 0.80M | 0.60M | 0.80M | 1.50M | 2.10M | 1.70M | 1.70M | 1.50M | 2.40M | 1.90M | ||||||||
| Receivables | 10.00M | 6.90M | 6.90M | 2.20M | 3.60M | 1.10M | 6.20M | 2.80M | 4.80M | 2.80M | 6.50M | 9.10M | 20.70M | 6.50M | ||||||||||||||
| Prepaid Assets | 9.34M | 9.19M | 10.30M | 9.51M | 10.39M | 9.31M | 11.18M | 8.84M | 7.10M | 7.59M | 6.98M | 7.08M | 7.99M | 9.80M | 14.02M | 10.55M | 11.77M | 13.88M | 13.66M | 12.95M | ||||||||
| Current Assets | 358.44M | 311.12M | 280.48M | 306.79M | 354.87M | 318.45M | 288.33M | 290.01M | 267.95M | 295.50M | 250.97M | 450.22M | 456.04M | 619.39M | 563.70M | 515.33M | 440.60M | 606.82M | 554.39M | 456.48M | ||||||||
| Non-Current Assets | ||||||||||||||||||||||||||||
| Property, Plant & Equipment (Net)PP&E (Net) | 9.57M | 11.34M | 13.52M | 15.51M | 16.50M | 17.16M | 17.72M | 18.50M | 16.58M | 16.81M | 17.87M | 18.56M | 17.07M | 17.76M | 18.45M | 18.77M | 20.50M | 22.49M | 21.70M | 20.01M | ||||||||
| Long-Term Investments | 121.48M | 137.19M | 123.69M | 51.54M | 69.12M | 63.88M | 48.45M | 27.46M | 9.88M | 7.42M | 10.29M | 9.38M | 9.47M | |||||||||||||||
| Other Non-Current Assets | 3.29M | 2.83M | 0.90M | 0.90M | 0.90M | 0.90M | 0.90M | 0.90M | 0.90M | 0.90M | 0.90M | 0.90M | 0.90M | 3.16M | 0.90M | 0.90M | 7.38M | 7.34M | 7.41M | 7.98M | ||||||||
| Non-Current Assets | 134.63M | 165.65M | 157.24M | 87.52M | 104.47M | 98.31M | 81.83M | 60.61M | 40.25M | 60.09M | 61.70M | 60.81M | 57.56M | 49.96M | 51.34M | 76.22M | 81.87M | 81.32M | 81.74M | 79.06M | ||||||||
| Assets | 493.07M | 476.77M | 437.72M | 394.31M | 459.34M | 416.76M | 370.15M | 350.62M | 308.19M | 355.60M | 312.67M | 511.03M | 513.60M | 669.34M | 615.04M | 591.55M | 522.47M | 688.13M | 636.13M | 535.54M | ||||||||
| Liabilities | ||||||||||||||||||||||||||||
| Current Liabilities | ||||||||||||||||||||||||||||
| Accounts Payables | 3.86M | 6.65M | 6.01M | 6.14M | 6.05M | 5.06M | 5.63M | 4.53M | 2.19M | 6.40M | 5.92M | 2.81M | 3.92M | 11.48M | 8.40M | 5.95M | 8.61M | 11.21M | 10.29M | 12.21M | ||||||||
| Payables | 3.86M | 6.65M | 6.01M | 6.14M | 6.05M | 5.06M | 5.63M | 4.53M | 2.19M | 6.40M | 5.92M | 2.81M | 3.92M | 11.48M | 8.40M | 5.95M | 8.61M | 11.21M | 10.29M | 12.21M | ||||||||
| Accumulated Expenses | 11.57M | 14.55M | 11.42M | 19.73M | 19.61M | 22.43M | 15.39M | 18.09M | 21.91M | 24.97M | 28.32M | 23.26M | 27.83M | 37.99M | 44.36M | 37.01M | 43.96M | 54.85M | 59.95M | 43.27M | ||||||||
| Other Accumulated Expenses | 0.63M | 0.66M | 0.55M | 2.24M | 1.65M | 1.50M | 1.02M | 1.24M | 0.83M | 0.75M | 0.74M | 1.00M | 0.66M | 2.27M | 2.69M | 1.04M | 1.73M | 2.10M | 1.93M | 1.30M | ||||||||
| Current Leases | 3.85M | 5.43M | 5.47M | 5.50M | 5.53M | 5.56M | 5.58M | 5.36M | 7.49M | 7.31M | 7.93M | 6.55M | 8.01M | 6.64M | 5.24M | 3.79M | 2.82M | 3.20M | 3.22M | |||||||||
| Current Taxes | 0.04M | 0.07M | 0.05M | 0.03M | 0.04M | |||||||||||||||||||||||
| Current Deferred Revenue | 35.25M | 41.21M | 43.19M | 41.32M | 36.34M | 37.63M | 38.30M | 44.06M | 32.04M | 48.10M | 46.08M | 46.77M | 48.00M | 38.36M | 30.59M | 27.42M | 25.99M | 17.58M | 18.75M | 13.32M | ||||||||
| Total Current Liabilities | 50.68M | 66.26M | 66.05M | 72.67M | 67.50M | 70.66M | 64.88M | 72.26M | 61.49M | 86.96M | 87.62M | 80.78M | 86.30M | 95.85M | 89.99M | 75.61M | 82.35M | 86.47M | 92.20M | 72.02M | ||||||||
| Non-Current Liabilities | ||||||||||||||||||||||||||||
| Non-Current Deffered Revenue | 66.38M | 59.02M | 55.43M | 45.86M | 41.55M | 35.97M | 26.12M | 14.68M | 10.24M | 45.02M | 34.46M | 38.67M | 29.86M | 26.21M | 24.15M | 21.64M | 15.18M | 10.01M | 7.58M | 5.97M | ||||||||
| Preferred Stock Liabilities | ||||||||||||||||||||||||||||
| Operating Leases | 9.19M | 10.33M | 9.04M | 7.75M | 6.43M | 5.11M | 3.76M | 2.64M | 23.12M | 21.85M | 20.89M | 20.59M | 20.29M | 19.98M | 46.70M | 52.70M | 52.91M | 55.45M | 54.92M | |||||||||
| Other Non-Current Liabilities | 0.80M | |||||||||||||||||||||||||||
| Total Non-Current Liabilities | 117.06M | |||||||||||||||||||||||||||
| Total Liabilities | 117.86M | 134.47M | 131.80M | 127.57M | 116.79M | 113.06M | 96.10M | 90.70M | 74.38M | 155.10M | 143.93M | 140.34M | 136.74M | 142.35M | 134.13M | 143.95M | 150.22M | 149.39M | 155.24M | 132.91M | ||||||||
| Shareholder's Equity | ||||||||||||||||||||||||||||
| Common Equity | 375.22M | 342.30M | 305.92M | 266.74M | 342.55M | 303.70M | 274.05M | 259.92M | 233.82M | 200.49M | 168.75M | 370.69M | 376.86M | 526.99M | 480.92M | 447.60M | 372.25M | 538.75M | 480.89M | 402.63M | ||||||||
| Liabilities and Shareholders Equity | 493.07M | 476.77M | 437.72M | 394.31M | 459.34M | 416.76M | 370.15M | 350.62M | 308.19M | 355.60M | 312.67M | 511.03M | 513.60M | 669.34M | 615.04M | 591.55M | 522.47M | 688.13M | 636.13M | 535.54M | ||||||||
| Retained Earnings | -183.20M | -220.89M | -263.43M | -308.83M | -354.54M | -401.25M | -442.00M | -466.30M | -503.24M | -545.20M | -586.72M | -631.30M | -680.22M | -738.77M | -795.12M | -838.60M | -925.00M | -1003.23M | -1100.00M | -1200.00M | ||||||||
| Treasury Shares |